WTO's COVID deal: more vaccine ‘enabler’ than IP waiver?

After several days and sleepless nights, members of the World Trade Organisation (WTO) finally agreed several key trade initiatives last week, including one that promises to suspend patent protection of the COVID-19 vaccines.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotechnology

Pfizer strikes $10.5 billion oncology deal with Chinese biotech

4 June 2026 The deal gives Pfizer access to 12 early-stage oncology programmes and marks the latest in a growing wave of high-value licensing agreements between Big Pharma and Chinese biotechs.

Careers

Dehns appoints head of litigation following wave of senior hires

4 June 2026 The new recruit, who will also support the firm’s UPC practice, brings more than 25 years’ experience and a “strong track record of handling technically and legally complex disputes” in the UK.

Careers

Chadha & Chadha hires former Remfry & Sagar patent partner

4 June 2026 The Indian firm has added a partner who brings more than three decades of experience advising clients across the pharmaceuticals, life sciences, technology and manufacturing sectors.

More features

Heated LNP litigation puts Moderna and Acuitas in the spotlight

Moderna loses key mRNA patent in European vaccine fight

CureVac targets Moderna with 10-patent suit over Spikevax

Patent office fee increases: What applicants must know

IndiaMart v CDSCO: A test of intermediary liability

mRNA litigation: Who’s winning, who’s filing, and what’s next

Moderna inks billion-dollar deal to settle long-running Spikevax dispute

Emotional Perception: What next for patent holders?

WTO's COVID deal: more vaccine ‘enabler’ than IP waiver?

More on this story

Editor's picks

Editor's picks

More features